Enfusion Valuation

Is ENFN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ENFN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ENFN ($9.89) is trading below our estimate of fair value ($15.31)

Significantly Below Fair Value: ENFN is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for ENFN?

Key metric: As ENFN is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for ENFN. This is calculated by dividing ENFN's market cap by their current revenue.
What is ENFN's PS Ratio?
PS Ratio4.7x
SalesUS$195.16m
Market CapUS$1.24b

Price to Sales Ratio vs Peers

How does ENFN's PS Ratio compare to its peers?

The above table shows the PS ratio for ENFN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average4.6x
AMPL Amplitude
4.5x9.0%US$1.3b
KARO Karooooo
5.1x12.3%US$1.3b
SUMO Sumo Logic
5x14.1%US$1.5b
OLO Olo
3.9x15.8%US$1.1b
ENFN Enfusion
4.8x16.7%US$1.2b

Price-To-Sales vs Peers: ENFN is expensive based on its Price-To-Sales Ratio (4.8x) compared to the peer average (4.5x).


Price to Sales Ratio vs Industry

How does ENFN's PS Ratio compare vs other companies in the US Software Industry?

81 CompaniesPrice / SalesEstimated GrowthMarket Cap
VYX NCR Voyix
0.6x-23.2%US$2.04b
PGY Pagaya Technologies
0.7x15.8%US$634.91m
XPER Xperi
0.8x1.8%US$378.82m
0.5x1.1%US$351.48m
ENFN 4.7xIndustry Avg. 5.1xNo. of Companies81PS048121620+
81 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: ENFN is good value based on its Price-To-Sales Ratio (4.8x) compared to the US Software industry average (5.1x).


Price to Sales Ratio vs Fair Ratio

What is ENFN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ENFN PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio4.7x
Fair PS Ratio3.7x

Price-To-Sales vs Fair Ratio: ENFN is expensive based on its Price-To-Sales Ratio (4.8x) compared to the estimated Fair Price-To-Sales Ratio (3.7x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ENFN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$9.89
US$9.61
-2.8%
10.6%US$11.00US$8.00n/a8
Nov ’25US$9.05
US$9.36
+3.4%
10.1%US$11.00US$8.00n/a8
Oct ’25US$9.08
US$9.36
+3.1%
10.1%US$11.00US$8.00n/a8
Sep ’25US$8.29
US$9.32
+12.4%
10.8%US$11.00US$8.00n/a7
Aug ’25US$9.24
US$9.82
+6.3%
12.7%US$12.00US$8.00n/a7
Jul ’25US$8.40
US$9.82
+16.9%
12.7%US$12.00US$8.00n/a7
Jun ’25US$9.41
US$9.82
+4.4%
12.7%US$12.00US$8.00n/a7
May ’25US$9.51
US$9.82
+3.3%
12.7%US$12.00US$8.00n/a7
Apr ’25US$9.24
US$9.82
+6.3%
12.7%US$12.00US$8.00n/a7
Mar ’25US$8.67
US$9.68
+11.6%
14.3%US$12.00US$8.00n/a7
Feb ’25US$7.78
US$9.82
+26.2%
12.7%US$12.00US$8.00n/a7
Jan ’25US$9.70
US$10.11
+4.2%
12.4%US$12.00US$8.00n/a7
Dec ’24US$10.10
US$9.96
-1.3%
13.2%US$12.00US$8.00n/a7
Nov ’24US$7.87
US$10.17
+29.2%
13.2%US$12.00US$8.00US$9.056
Oct ’24US$8.97
US$10.17
+13.3%
13.2%US$12.00US$8.00US$9.086
Sep ’24US$8.60
US$10.14
+17.9%
12.3%US$12.00US$8.00US$8.297
Aug ’24US$10.67
US$11.21
+5.1%
13.9%US$14.00US$9.00US$9.247
Jul ’24US$11.22
US$11.21
-0.05%
13.9%US$14.00US$9.00US$8.407
Jun ’24US$7.81
US$11.21
+43.6%
13.9%US$14.00US$9.00US$9.417
May ’24US$8.56
US$12.07
+41.0%
11.4%US$14.00US$10.00US$9.517
Apr ’24US$10.50
US$12.25
+16.7%
11.5%US$14.00US$10.00US$9.246
Mar ’24US$10.25
US$11.90
+16.1%
16.0%US$14.00US$9.50US$8.675
Feb ’24US$11.89
US$11.90
+0.08%
16.0%US$14.00US$9.50US$7.785
Jan ’24US$9.67
US$14.00
+44.8%
4.5%US$15.00US$13.00US$9.705
Dec ’23US$9.95
US$14.40
+44.7%
7.1%US$16.00US$13.00US$10.105
Nov ’23US$13.75
US$14.00
+1.8%
9.0%US$16.00US$13.00US$7.875

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies